Skip to main content
CVS GROUP PLC logo

CVS GROUP PLC — Investor Relations & Filings

Ticker · CVSG ISIN · GB00B2863827 LEI · 213800J41XDQ2NX48O05 IL Professional, scientific and technical activities
Open in API
Filings indexed 790 across all filing types
Latest filing 2024-10-04 Director's Dealing
Country GB United Kingdom
Listing IL CVSG

About CVS GROUP PLC

https://www.cvsuk.com/

CVS Group PLC is an integrated veterinary services provider. Established in 1999, the company operates a large network of veterinary practices, offering a comprehensive range of clinical services for animals. The group's operations are vertically integrated, encompassing not only primary care and specialist referral practices but also diagnostic laboratories, pet crematoria, and an online retail business. The company focuses on delivering high-quality clinical care and support services across its divisions, with a stated purpose of providing the best possible care to animals.

Recent filings

Filing Released Lang Actions
Long Term Incentive Plan Awards and PDMR Dealing
Director's Dealing Classification · 1% confidence The document is an official announcement from CVS Group plc, identified by the RNS Number and the header 'RNS Number : 0657H'. The content explicitly details the 'Grant of Options' under a Long Term Incentive Plan (LTIP) to Directors and senior employees, including the CEO and CFO. This type of filing, which reports personal share transactions or grants to Persons Discharging Managerial Responsibilities (PDMRs) in compliance with UK MAR, falls under the category of Director's Dealing (DIRS). Although it involves options, the core purpose is reporting insider transactions/awards, not general capital changes (SHA) or remuneration reports (DEF 14A). Since it specifically details executive share dealings, DIRS is the most appropriate classification.
2024-10-04 English
Notification of major holdings
Major Shareholding Notification Classification · 1% confidence The document is titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 7342G' by CVS Group plc on October 3, 2024. It details an acquisition of voting rights by Tweedy, Browne Company LLC, crossing a threshold (5.130000%). This specific form (TR-1) is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is the most specific category available for this type of disclosure.
2024-10-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the header "RNS Number : 3388G" and contains information about the exercise of employee stock options, the resulting issuance of new ordinary shares, and the resulting total number of voting rights (71,738,473). This type of announcement, detailing changes in the total share capital and voting rights, is a standard regulatory disclosure in the UK market, often disseminated via RNS. Since the content specifically addresses the total voting rights denominator for shareholders (a regulatory requirement) and is short, it fits best under the general category for regulatory announcements that aren't specifically about dividends, director dealings, or major shareholdings crossing a threshold, but rather a routine capital structure update. However, the core subject is the calculation of total voting rights following a share issuance. This is closely related to share capital changes (SHA) or general regulatory filings (RNS). Given the explicit mention of the total voting rights figure used for FCA Disclosure Guidance, and the RNS distribution footer, it is a regulatory announcement. Since it is not a specific event like a dividend (DIV) or director dealing (DIRS), and it's not a presentation (IP) or a full report (10-K/IR), the most appropriate general category for this type of routine regulatory update is RNS, although it touches upon share capital changes. Since the document explicitly states the total voting rights figure, which is a key component of regulatory disclosure, RNS is the best fit as a general regulatory filing.
2024-10-01 English
Final results for the year ended 30 June 2024
Earnings Release Classification · 1% confidence The document is titled 'CVS Group plc Final results for the year ended 30 June 2024'. It contains detailed financial highlights, tables comparing 2024 results to 2023, notes explaining financial metrics (like Adjusted EBITDA, LFL sales), a CEO comment, and an outlook section. This structure is characteristic of a company reporting its full annual financial performance. Although it is distributed via RNS (RNS Number: 7767F), the content itself is the comprehensive annual report summary, which aligns best with the 'Annual Report' definition (10-K, although this is a UK company filing, the content matches the scope of an annual report). Since the document is very long (120k characters) and contains the full results, it is the report itself, not just an announcement of the report (RPA). Given the options, '10-K' is the closest fit for a comprehensive annual financial report, even if the company is UK-listed and might file a UK equivalent. FY 2024
2024-09-26 English
Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange.' The content discusses the 'Exercise of Options and Total Voting Rights' following an employee share scheme exercise, resulting in a change to the total number of voting rights (71,738,224). This type of mandatory disclosure regarding share capital changes and voting rights, distributed via the RNS system, fits best under the general 'Regulatory Filings' category (RNS) as it is a specific regulatory announcement that isn't covered by more specific codes like DIRS (Director's Dealing) or SHA (Share Issue/Capital Change, although it involves new shares, the primary focus is the resulting voting rights notification). Given the explicit RNS distribution source and the nature of the announcement (Total Voting Rights update), RNS is the most appropriate classification.
2024-09-02 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly starts with 'RNS Number : 4783Y' and contains standard regulatory boilerplate language from 'RNS, the news service of the London Stock Exchange.' The content discusses the exercise of employee stock options, the resulting issuance of new ordinary shares, and the resulting update to the total number of voting rights (71,737,601). This type of mandatory disclosure regarding share capital changes and voting rights notification, distributed via RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights Update' or 'Share Option Exercise Disclosure' that is more precise than RNS, and it is not a Director's Dealing (DIRS) or a Share Issue/Capital Change (SHA) which usually relates to broader capital structure changes or offerings, although it does involve share issuance. Given the context of a standard, short regulatory news service announcement, RNS is the most appropriate classification.
2024-07-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.